Cardioloxía
Servicio
Javier
Goicolea Ruigómez
Publicacións nas que colabora con Javier Goicolea Ruigómez (50)
2023
-
Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry
Minerva cardiology and angiology, Vol. 71, Núm. 3, pp. 284-293
-
Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 253-260
2022
-
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study
European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316
-
Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396
-
Plaque modification in calcified chronic total occlusions: the PLACCTON study
Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 213-222
-
The TriClip system for edge-to-edge transcatheter tricuspid valve repair. A Spanish multicenter study
Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 798-805
2021
-
Percutaneous mitral valve repair: Outcome improvement with operator experience and a second-generation device
Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-10
2020
-
Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair
Journal of the American College of Cardiology, Vol. 76, Núm. 21, pp. 2463-2473
-
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial
EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921
2019
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: Twoyear follow-up of the SYNTAX II study
EuroIntervention, Vol. 15, Núm. 3, pp. E244-A252
-
Effect of Successful Edge-to-Edge Mitral Valve Repair on Ventricular Arrhythmic Burden in Patients With Functional Mitral Regurgitation and Implantable Cardiac Devices
American Journal of Cardiology, Vol. 124, Núm. 7, pp. 1113-1119
-
Left atrial appendage occlusion as adjunctive therapy to anticoagulation for stroke recurrence
Journal of Invasive Cardiology, Vol. 31, Núm. 8, pp. 212-216
-
MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design
Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 1, pp. 64-70
-
Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial
Circulation, Vol. 140, Núm. 23, pp. 1904-1916
-
Rentabilidad diagnóstica y seguridad de la biopsia endomiocárdica en corazón nativo en un centro español de referencia
REC: Interventional Cardiology, Vol. 1, Núm. 2, pp. 99-107
-
Resultados de la intervención coronaria percutánea de oclusiones crónicas totales en pacientes con trasplante cardiaco
REC: Interventional Cardiology, Vol. 1, Núm. 3, pp. 152-160
-
Transcatheter Tricuspid Replacement With a Dedicated Self-expandable Valve: The GATE System
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1081-1083
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
-
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
The Lancet, Vol. 392, Núm. 10151, pp. 940-949
2017
-
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134